Recombinant enzyme for the accurate insertion of dna sequences in eukaryotic cells
AssigneeRensselaer Polytechnic Institute
InventorsWILLIAM G. LAWLER, MATTHEOS AG KOFFAS
Life of this patent
Estimating the term…
Loading patent…
AssigneeRensselaer Polytechnic Institute
InventorsWILLIAM G. LAWLER, MATTHEOS AG KOFFAS
Estimating the term…
A construct for site-specific insertion of DNA fragments and transgenes into a genome includes a recombinant enzyme. The enzyme includes a modified HIV-1 integrase (HIV IN) tetramer having a plurality of mutations to favor a heterodimer of heterodimers construction with first and second outer monomers bound to first and second inner monomers, respectively. Transcription Activator Like Effectors (TALEs) are bound to N-terminal regions of the outer monomers via polypeptide linkers. The two TALEs grant the enzyme sequence specificity and prevent non-specific interactions with a target DNA structure. The modified HIV IN monomers ensure binding of TALEs to the outer-most monomers and arrangement of the TALEs relative to the HIV IN's catalytic region. Polynucleotides are bound to inner monomers of the HIV IN. Upon transport to the nucleus, either alone or within a lentiviral capsid, the TALEs interact with the DNA to localize the HIV IN, which then integrates the polynucleotides.
A recombinant enzymatic gene editing system, comprising:
A method of editing genomic material in a target organism, comprising:
A recombinant enzymatic gene editing system, comprising:
Dependencies are inferred from the claim text.